Blue water vaccines reports first quarter 2022 financial results and recent business developments

Cincinnati, may 13, 2022 (globe newswire) -- blue water vaccines inc. (“bwv” or “blue water vaccines” or “the company”), today announced its financial results for the first quarter ended march 31, 2022 and provided an update on recent business developments and progress. blue water vaccines is a pre-clinical stage biotechnology company developing vaccines against multiple infectious diseases, including influenza, norovirus, rotavirus, and acute otitis media (aom) from streptococcus pneumoniae colonization.
BWV Ratings Summary
BWV Quant Ranking